Incidence of Hypoglycemia in Insulin-treated Type 2 Diabetes Higher than Previously Recognized Hypoglycemia may be more common patients with type 2 diabetes who are treated with insulin than was previously thought.

Beta-Blockers Improve Survival Outcomes In Diabetics With Heart Failure Therapy improves outcomes for diabetic patients with chronic heart failure, albeit not to the extent realized by patients without diabetes.

Renal Disease Progresses in Slowly Type 2 Diabetics Type 2 diabetic patients without overt nephropathy have a significant, but slow, course of renal insufficiency.

Combining rosiglitazone, metformin, and insulin aspart improved glucose metabolism in obese type 2 diabetic patients compared with mixed insulin alone.

St. Petersburg Times, Dec 7, 2003 TheraSense Files Premarket Approval Application for Freestyle Navigator(TM) Continuous Glucose Monitor– The PMA filing follows recently presented clinical data on Navigator that included results of home-use trials involving 102 subjects at 7 clinical sites. FreeStyle Navigator is a continuous glucose monitor designed to replace …

Excess Risk of Stomach, Uterine Cancer Seen in Type 1 Diabetics The excess risks are most striking for malignancies of the stomach, cervix and endometrium. Diabetics were 4.8 times more likely than the general population to develop cancer

Whole Life does not take place in cyberspace on the internet but is a real game of Aliens, Weapons, and a Health meter. Each time you succeed and reach a new level, you change the real world around you. Many of your challengers in other games are just playing. They …

Aggressive blood pressure control may be the most important factor in preventing adverse outcomes in patients with type 2 diabetes.

Enalapril treatment resulted in an absolute risk reduction of 22.4 percentage points for the development of clinical albuminuria over five years.

Could this be in store for the U.S. and other countries?